Back
ResMed 10K Form
Sell
44
RMD
ResMed
Last Price:
$232.38
Seasonality Move:
4.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-27 | 10Q | RMD/ResMed Quarterly |
2023-04-28 | 10Q | RMD/ResMed Quarterly |
2023-01-27 | 10Q | RMD/ResMed Quarterly |
2022-10-28 | 10Q | RMD/ResMed Quarterly |
2022-04-29 | 10Q | RMD/ResMed Quarterly |
2022-01-28 | 10Q | RMD/ResMed Quarterly |
Receive RMD News And Ratings
See the #1 stock for the next 7 days that we like better than RMD
RMD Financial Statistics
Sales & Book Value
Annual Sales: | $4.7B |
---|---|
Cash Flow: | $305.9M |
Price / Cash Flow: | 25.48 |
Annual Sales: | $35.39 |
Price / Book: | 6.57 |
Profitability
EPS (TTM): | 7.55000 |
---|---|
Net Income (TTM): | $1.1B |
Gross Margin: | $2.7B |
Return on Equity: | 23.76% |
Return on Assets: | 16.1% |
ResMed Earnings Forecast
Key ResMed Financial Ratios
-
The Gross Profit Margin over the past 32 years for RMD is 56.67%.
-
The Selling, General & Administrative Expenses for RMD have been equal to 19.57% of Gross Profit Margin.
-
The Research & Development expenses have been 6.56% of Revenue.
-
The Interest Expense is 4.48% of Operating Income.
-
The Net Earning history of RMD is 21.79% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 25 years.
ResMed Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | RMD |
CUSIP: | 761152 |
Website: | resmed.com |
Debt
Debt-to-Equity Ratio: | 0.13 |
---|---|
Current Ratio: | 2.92 |
Quick Ratio: | 1.37 |
Price-to-Earnings
Trailing P/E Ratio: | 33.61 |
---|---|
Forward P/E Ratio: | 22.59 |